表紙
市場調查報告書

免疫血液學市場: 全球產業趨勢,佔有率,規模,成長,機會,預測(2020年∼2025年)

Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版商 IMARC Services Private Limited 商品編碼 952973
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
免疫血液學市場: 全球產業趨勢,佔有率,規模,成長,機會,預測(2020年∼2025年) Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日期: 2020年07月18日內容資訊: 英文 114 Pages
簡介

全球免疫血液學市場,從2014年到2019年之間以約6%的年複合成長率成長。全球白血病與其他血液疾病增加,新興國家的醫療基礎設施的改善,血庫和外傷中心的發展等,是帶動該市場成長的主要原因,採血,處理,檢驗,保存相關活動在大眾之間的認識高漲,帶給免疫血液學設備的需求好的影響。再加上創新的輸血系統和完全自動化設備的開發等,各種技術的進步推動市場成長。

本報告提供全球免疫血液學市場的相關調查,市場成果,各產品、技術、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球市場

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 市場明細:各產品

  • 系統分析
  • 試劑與消耗品

第7章 市場明細:各技術

  • 生物晶片
  • 凝膠卡
  • 微孔盤
  • 聚合酵素鏈鎖反應
  • 紅血球到達磁科技(EMT)
  • 其他

第8章 市場明細:各用途

  • 血液相關疾病
  • HIV
  • 肝炎
  • 輸血
  • 其他

第9章 市場明細:各終端用戶

  • 醫院
  • 血庫
  • 診斷研究所
  • 其他

第10章 市場明細:各地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 各國

第11章 SWOT分析

第12章 價值鏈分析

第13章 波特五力分析

第14章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Abbott
    • Antisel
    • BD (Becton Dickinson and Company)
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd.
    • Grifols S.A.
    • Merck KGaA
    • MTC Invitro Diagnostics AG
    • Ortho-Clinical Diagnostics Inc (The Carlyle Group)
    • Thermo Fisher Scientific Inc.
目錄
Product Code: SR1019L7_Report

The global immunohematology market grew at a CAGR of around 6% during 2014-2019. Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system. It is used to study the presence of antigens in the blood and their reaction with antibodies that can either cause hemolysis or red blood cell (RBC) agglutination. Various immunohematology tests are conducted to ensure safe blood transfusion and prevent undesired immunity-, transplant-, and pregnancy-related reactions, and to diagnose blood related disorders and diseases such as HIV, Hepatitis, etc. They utilize various chemicals and devices, such as reagents, and automatic and semi-automatic analyzers that are based on the technology of microplates, biochips, gel cards, polymerase chain reaction and erythrocyte-magnetized technology (EMT).

The increasing prevalence of leukemia and other hematological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, improvements in the healthcare infrastructure and the development of blood banks and trauma centers, especially in developing countries, is also providing a boost to the market growth. Increasing awareness among the masses regarding the activities associated with blood collection, processing, testing and storage has further created a positive impact on the demand for immunohematology devices. Additionally, various technological advancements, such as the development of innovative transfusion systems and fully-automated devices, are acting as other growth-inducing factors. These next-generation immunohematology devices aid in enhancing the efficacy of the diagnosis, minimizing analysis time and risk of human error, and providing emergency assistance to the patients. Other factors, including an increasing number of blood donation camps and awareness programs, along with improvements in the healthcare infrastructure, are projected to drive the market further. Looking forward, IMARC Group expects the global immunohematology market to continue its moderate growth during the next five years.

Breakup by Product:

  • Analyzing Systems
  • Reagents and Consumables

Breakup by Technology:

  • Biochips
  • Gel Cards
  • Microplates
  • Polymerase Chain Reaction
  • Erythrocyte-Magnetized Technology (EMT)
  • Others

Breakup by Application:

  • Blood-Related Disorders
  • HIV
  • Hepatitis
  • Blood Transfusion
  • Others

Breakup by End-User:

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott, Antisel, BD (Becton Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Merck KGaA, MTC Invitro Diagnostics AG, Ortho-Clinical Diagnostics Inc (The Carlyle Group), Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global immunohematology market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global immunohematology market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunohematology market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohematology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Analyzing Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Biochips
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gel Cards
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microplates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Polymerase Chain Reaction
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Erythrocyte-Magnetized Technology (EMT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Blood-Related Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 HIV
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hepatitis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Transfusion
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Blood Banks
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Antisel
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Grifols S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 MTC Invitro Diagnostics AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Ortho-Clinical Diagnostics Inc (The Carlyle Group)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohematology Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohematology Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Immunohematology Market: Breakup by Product (in %), 2019
  • Figure 4: Global: Immunohematology Market: Breakup by Technology (in %), 2019
  • Figure 5: Global: Immunohematology Market: Breakup by Application (in %), 2019
  • Figure 6: Global: Immunohematology Market: Breakup by End-User (in %), 2019
  • Figure 7: Global: Immunohematology Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Immunohematology Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Immunohematology (Analyzing Systems) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Immunohematology (Analyzing Systems) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Immunohematology (Reagents and Consumables) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Immunohematology (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Immunohematology (Biochips) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Immunohematology (Biochips) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Immunohematology (Gel Cards) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Immunohematology (Gel Cards) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Immunohematology (Microplates) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Immunohematology (Microplates) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Immunohematology (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Immunohematology (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Immunohematology (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Immunohematology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Immunohematology (Blood-Related Diseases) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Immunohematology (Blood-Related Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Immunohematology (HIV) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Immunohematology (HIV) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Immunohematology (Blood-Related Diseases) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Immunohematology (Blood-Related Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Immunohematology (Blood Transfusion) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Immunohematology (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Immunohematology (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Immunohematology (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Immunohematology (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Immunohematology (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Immunohematology (Blood Banks) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Immunohematology (Blood Banks) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Immunohematology (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Immunohematology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: Global: Immunohematology (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: Global: Immunohematology (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: North America: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: North America: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: United States: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: United States: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Canada: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Canada: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: Asia Pacific: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: Asia Pacific: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: China: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: China: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: Japan: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: Japan: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: India: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: India: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: South Korea: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: South Korea: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Australia: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Australia: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Indonesia: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Indonesia: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Others: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Europe: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Europe: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: Germany: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: Germany: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: France: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: France: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: United Kingdom: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: United Kingdom: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Italy: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Italy: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Spain: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Spain: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Russia: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Russia: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Others: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Latin America: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Latin America: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Brazil: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Brazil: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Mexico: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Mexico: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Others: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Middle East and Africa: Immunohematology Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 90: Middle East and Africa: Immunohematology Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 91: Global: Immunohematology Industry: SWOT Analysis
  • Figure 92: Global: Immunohematology Industry: Value Chain Analysis
  • Figure 93: Global: Immunohematology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohematology Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Immunohematology Market Forecast: Breakup by Product (in Million US$), 2020-2025
  • Table 3: Global: Immunohematology Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 4: Global: Immunohematology Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 5: Global: Immunohematology Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 6: Global: Immunohematology Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Immunohematology Market Structure
  • Table 8: Global: Immunohematology Market: Key Players